Table 3.

Summary of patient outcomes among patients who elected to undergo oocyte cryopreservation, including age at first oocyte cryopreservation cycle, type of sex chromosome disorder, hormonal measurements at first oocyte cryopreservation cycle, number of cycle attempts, number of oocyte retrievals, and total number of oocytes retrieved and frozen.

Patient ID	Age at first cycle	Sex chromosome disorder	E2 (pg/mL) at first cycle	FSH (mIU/mL) at first cycle	AMH (ng/ml)	# of oocyte cryopreservation attempts	# of retrievals	Total oocytes retrieved	Total oocytes frozen	MII oocytes frozen	MI oocytes frozen	GV oocytes frozen
1	13	Mosaic TS	38	5.2	2.99	1	1	14	14	12	2	0
2	14	TS	41	0.4	< 0.16	1	1	4	4	2	1	1
3	14	Mosaic TS	27	4.5	2.08	1	1	21	21	16	3	2
4	14	TS*	23	20.6	0.03	3	0	0	0	0	0	0
5	15	TS	23	3.9	Unknown	2	0	0	0	0	0	0
6	15	TS*	30	0.2	Unknown	1	1	15	15	15	0	0
7	15	Mosaic TS	109	1.8	< 0.003	1	0	0	0	0	0	0
8	16	Mosaic TS	< 20	0.5	1.63	3	2	19	18	8	6	4
9	16	47XXX	44	3.3	1.04	2	2	22	18	16	0	2
10	17	Mosaic TS	49	1.1	Unknown	9	4	3	3	0	3	0
11	18	Mosaic TS	35	< 0.1	Unknown	2	0	0	0	0	0	0
12	21	Mosaic TS	80	6.5	2.6	1	1	22	21	12	4	5
13	21	TS	21	9.3	< 0.03	3	2	2	0	0	0	0
14	21	Mosaic TS	42	5.4	5.34	1	1	19	19	14	0	5
Median (range) or mean ± SD	16.4 ± 2.8		36.5 (20–109)	4.5 ± 5.4	1.6 + 1.7	1.5 (1–9)	1 (0–4)	9 (0–22)	9 (0–21)	5 (0–16)	0 (0–6)	0 (0–5)

TS Turner syndrome; MII, mature oocyte; MI, immature oocyte; GV, germinal vesicle. *Patients whose mosaic status was not confirmed